Recent Finacing
Recent Raise
Entrada Therapeutics develops intracellular biologics using its Endosomal Escape Vehicle platform to deliver oligonucleotides, proteins, peptides, antibodies and enzymes for neuromuscular and other rare monogenic diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
